OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2023
(4)
2021
(4)
2024
(3)
2025
(2)
2022
(1)
2017
(1)
2015
(1)
2013
(1)
2012
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Not available
S-EPMC4496027
|
biostudies-literature
Cite
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality.
Not available
S-EPMC8244638
|
biostudies-literature
Cite
Effects of eight neuropsychiatric copy number variants on human brain structure.
Not available
S-EPMC8292542
|
biostudies-literature
Cite
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study.
Not available
S-EPMC9469080
|
biostudies-literature
Cite
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
Not available
S-EPMC9916499
|
biostudies-literature
Cite
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.
Not available
S-EPMC5282828
|
biostudies-literature
Cite
SMIM1 absence is associated with reduced energy expenditure and excess weight.
Not available
S-EPMC7617389
|
biostudies-literature
Cite
Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.
Not available
S-EPMC3338281
|
biostudies-literature
Cite
Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.
Not available
S-EPMC3073398
|
biostudies-literature
Cite
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis.
Not available
S-EPMC12583412
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets